| Antitumor activity of thalidomide in refractory multiple myeloma S Singhal, J Mehta, R Desikan, D Ayers, P Roberson, P Eddlemon, ... New England Journal of Medicine 341 (21), 1565-1571, 1999 | 3631 | 1999 |
| Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America TJ Walsh, EJ Anaissie, DW Denning, R Herbrecht, DP Kontoyiannis, ... Clinical infectious diseases 46 (3), 327-360, 2008 | 3572 | 2008 |
| Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection … DP Kontoyiannis, KA Marr, BJ Park, BD Alexander, EJ Anaissie, TJ Walsh, ... Clinical infectious diseases 50 (8), 1091-1100, 2010 | 1611 | 2010 |
| Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) PG Pappas, BD Alexander, DR Andes, S Hadley, CA Kauffman, A Freifeld, ... Clinical Infectious Diseases 50 (8), 1101-1111, 2010 | 1581 | 2010 |
| The molecular classification of multiple myeloma F Zhan, Y Huang, S Colla, JP Stewart, I Hanamura, S Gupta, J Epstein, ... Blood 108 (6), 2020-2028, 2006 | 1259 | 2006 |
| Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever TJ Walsh, P Pappas, DJ Winston, HM Lazarus, F Petersen, J Raffalli, ... New England Journal of Medicine 346 (4), 225-234, 2002 | 1225 | 2002 |
| Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry DL Horn, D Neofytos, EJ Anaissie, JA Fishman, WJ Steinbach, AJ Olyaei, ... Clinical infectious diseases 48 (12), 1695-1703, 2009 | 1220 | 2009 |
| Fusarium Infections in Immunocompromised Patients M Nucci, E Anaissie Clinical microbiology reviews 20 (4), 695-704, 2007 | 1129 | 2007 |
| A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 JD Shaughnessy Jr, F Zhan, BE Burington, Y Huang, S Colla, I Hanamura, ... Blood 109 (6), 2276-2284, 2007 | 1083 | 2007 |
| The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species D Abi-Said, E Anaissie, O Uzun, I Raad, H Pinzcowski, S Vartivarian Clinical Infectious Diseases 24 (6), 1122-1128, 1997 | 1061 | 1997 |
| Taxonomy, biology, and clinical aspects of Fusarium species PE Nelson, MC Dignani, EJ Anaissie Clinical microbiology reviews 7 (4), 479-504, 1994 | 986 | 1994 |
| Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH … D Neofytos, D Horn, E Anaissie, W Steinbach, A Olyaei, J Fishman, ... Clinical Infectious Diseases 48 (3), 265-273, 2009 | 924 | 2009 |
| Thalidomide and hematopoietic-cell transplantation for multiple myeloma B Barlogie, G Tricot, E Anaissie, J Shaughnessy, E Rasmussen, ... New England Journal of Medicine 354 (10), 1021-1030, 2006 | 882 | 2006 |
| Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells F Zhan, J Hardin, B Kordsmeier, K Bumm, M Zheng, E Tian, R Sanderson, ... Blood, The Journal of the American Society of Hematology 99 (5), 1745-1757, 2002 | 814 | 2002 |
| Total therapy with tandem transplants for newly diagnosed multiple myeloma B Barlogie, S Jagannath, KR Desikan, S Mattox, D Vesole, D Siegel, ... Blood, The Journal of the American Society of Hematology 93 (1), 55-65, 1999 | 794 | 1999 |
| Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases TJ Walsh, JW Hiemenz, NL Seibel, JR Perfect, G Horwith, L Lee, JL Silber, ... Clinical Infectious Diseases 26 (6), 1383-1396, 1998 | 785 | 1998 |
| Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement I Raad, W Costerton, U Sabharwal, M Sadlowski, E Anaissie, GP Bodey Journal of Infectious Diseases 168 (2), 400-407, 1993 | 750 | 1993 |
| Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients B Barlogie, R Desikan, P Eddlemon, T Spencer, J Zeldis, N Munshi, ... Blood, The Journal of the American Society of Hematology 98 (2), 492-494, 2001 | 743 | 2001 |
| Fusarium, a Significant Emerging Pathogen in Patients With Hematologic Malignancy: Ten Years' Experience at a Cancer Center and Implications for Management EI Boutati, EJ Anaissie Blood, The Journal of the American Society of Hematology 90 (3), 999-1008, 1997 | 739 | 1997 |
| Infections due to emerging and uncommon medically important fungal pathogens TJ Walsh, A Groll, J Hiemenz, R Fleming, E Roilides, E Anaissie Clinical Microbiology and Infection 10, 48-66, 2004 | 725 | 2004 |
